Concepedia

Jean‐Louis Bayart

JB

11

Publications

619

Citations

11

H-Index

2019

Active since

Affiliations

Clinique Saint-Joseph(Current)

University of Namur

Clinique Saint Pierre

UCLouvain

Cliniques Universitaires Saint-Luc

Jean‐Louis Bayart is an author at Clinique Saint-Joseph specializing in medicine, vaccine efficacy, and vaccine development.

ORCID

Top concepts

Publications per year

2019–2023

11

Publications

11

Antibody titres decline 3-month post-vaccination with BNT162b2

Julien Favresse, Jean‐Louis Bayart, François Mullier et al. · Emerging Microbes & Infections · 2021 · 166 citations · Full text

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot et al. · Vaccines · 2021 · 128 citations · Full text

, , +16

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)

Julien Favresse, Jean‐Louis Bayart, François Mullier et al. · Clinical Microbiology and Infection · 2021 · 71 citations · Full text

, , +6

Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis

Jean‐Louis Bayart, Bernard Hanseeuw, Adrian Ivanoiu et al. · Journal of Neurology · 2019 · 58 citations · Full text

, , +12

Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers

Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot et al. · 2021 · 54 citations · Full text

, , +21

Rows per page

1–5 of 11